Botanical species · safety record
Anethum graveolens
The EFSA Compendium of Botanicals holds 35 constituent measurements, 1 adverse-effect record and 2 genotoxicity assays for Anethum graveolens. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.
Accepted name in source: Anethum graveolens L.
Regulatory presence
Health Canada's Licensed Natural Health Products Database holds 24 licensed products naming Anethum graveolens as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.
Extract types on licence
Source material stated
What the records describe
Constituents measured
- Carvone12
- Dillapiole5
- Dihydrocarvone3
- Myristicin3
- Umbelliferone3
- Coumarins2
- Scopoletin2
- (+)-pulegone1
- Bergapten1
- Esculetin1
Plant parts
- Seed16
- Fruit unspecified12
- Aerial part of plants6
- Leaves2
Preparations
- Solvent extraction23
- Essential oil13
Effect types
- Reproductive1
Target tissues
- Urogenital1
Recorded constituents
What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.
| Substance | Plant part | Preparation | Concentration | Analytical method | Source |
|---|---|---|---|---|---|
| (+)-pulegone | Aerial part of plants | Solvent extraction | 6.67 Percent | GC-MS | Resolve DOI |
| Carvone | Seed | Essential oil | 58.11 Percent | Unspecified | Resolve DOI |
| Carvone | Fruit unspecified | Essential oil | 66.6 Percent | GC-MS | Resolve DOI |
| Carvone | Seed | Solvent extraction | ≥ 45.84 Percent | GC-MS | Resolve DOI |
| Carvone | Seed | Solvent extraction | ≤ 48.15 Percent | GC-MS | Resolve DOI |
| Carvone | Aerial part of plants | Solvent extraction | 16.2 Percent | GC-MS | Resolve DOI |
| Carvone | Fruit unspecified | Essential oil | 22 Percent | GC-MS | Resolve DOI |
| Carvone | Seed | Solvent extraction | ≥ 0.032 Percent | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | Resolve DOI |
| Carvone | Seed | Solvent extraction | ≤ 0.072 Percent | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | Resolve DOI |
| Carvone | Aerial part of plants | Essential oil | 6.66 Percent | Unspecified | Resolve DOI |
| Coumarins | Leaves | Solvent extraction | ≥ 1.3 Microgram/millilitre | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Coumarins | Leaves | Solvent extraction | ≤ 9.5 Microgram/millilitre | High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC) | Resolve DOI |
| Dihydrocarvone | Aerial part of plants | Solvent extraction | 1.03 Percent | GC-MS | Resolve DOI |
| Dihydrocarvone | Fruit unspecified | Essential oil | ≥ 1.3 Percent | GC-MS | Resolve DOI |
| Dihydrocarvone | Fruit unspecified | Essential oil | ≤ 2.1 Percent | GC-MS | Resolve DOI |
| Dillapiole | Aerial part of plants | Solvent extraction | 6.66 Percent | GC-MS | Resolve DOI |
| Dillapiole | Fruit unspecified | Essential oil | 26.8 Percent | GC-MS | Resolve DOI |
| L-piperitone | Fruit unspecified | Essential oil | 8.2 Percent | GC-MS | Resolve DOI |
| Myristicin | Seed | Solvent extraction | ≤ 0.042 Percent | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | Resolve DOI |
| Myristicin | Seed | Solvent extraction | ≥ 0.015 Percent | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | Resolve DOI |
| Myristicin | Fruit unspecified | Essential oil | 3.2 Percent | GC-MS | Resolve DOI |
| Umbelliferone | Seed | Solvent extraction | ≤ 0.007 Percent | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | Resolve DOI |
| Umbelliferone | Seed | Solvent extraction | ≥ 0.002 Percent | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | Resolve DOI |
| Bergapten | Fruit unspecified | Solvent extraction | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
| Carvone | Seed | Essential oil | ≥ 36.53 Percent | GC-MS | No resolvable identifier |
| Carvone | Seed | Essential oil | ≤ 81.15 Percent | GC-MS | No resolvable identifier |
| Carvone | Seed | Solvent extraction | 7.07 Nanogram/gram | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | No resolvable identifier |
| Dillapiole | Seed | Solvent extraction | 5.87 Nanogram/gram | Gelpermeation, High Performance Thin Layer Chromatography (HPTLC) | No resolvable identifier |
| Dillapiole | Seed | Essential oil | ≥ 0.02 Percent | GC-MS | No resolvable identifier |
| Dillapiole | Seed | Essential oil | ≤ 6.3 Percent | GC-MS | No resolvable identifier |
| Esculetin | Fruit unspecified | Solvent extraction | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
| Scopoletin | Aerial part of plants | Solvent extraction | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
| Scopoletin | Fruit unspecified | Solvent extraction | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
| Umbelliferone | Fruit unspecified | Solvent extraction | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
| Umbelliprenin | Fruit unspecified | Solvent extraction | — | Standard Chromatographic tests (paper- thin layer- and column chromatography) | No resolvable identifier |
Recorded adverse effects
Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.
| Effect | Target tissue | Plant part | Preparation | Test organism | Test type | Source |
|---|---|---|---|---|---|---|
| Reproductive | Urogenital | Seed | Solvent extraction | Rat (as animal) | Reproduction toxicity | Resolve DOI |
Genotoxicity testing
Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.
| Outcome | Endpoint | Test | Tested organism | Metabolic activation | Source |
|---|---|---|---|---|---|
| Positive | gene mutation | bacterial reverse mutation assay | Bacteria (as organism) | With and without | Resolve DOI |
| Positive | — | somatic mutation assay in Drosophila | Drosophila melanogaster (as animal) | — | Resolve DOI |
Cited sources
The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.
- Lazutka, JR., Mierauskiene, J., Slapsyte, G., Dedonyte, V. Genotoxicity of dill (Anethum graveolens L.), peppermint (Mentha x piperita L.) and pine (Pinus sylvestris L.) essential oils in human lymphocytes and Drosophila melanogaster . Food and chemical toxicology, 2001, vol. 39, no. 5, p. 485-492. DOI
- Sousa, Rose Marie O. F., Rosa, Jose S., Oliveira, Luisa., Cunha, Ana., Fernandes-Ferreira, Manuel. Activities of Apiaceae essential oils and volatile compounds on hatchability, development, reproduction and nutrition of Pseudaletia unipuncta (Lepidoptera: Noctuidae) . Industrial crops and products, 2015, vol. 63, p. 226-237. DOI
- Wang, XS., Kapoor, V., Smythe, GA. Extraction and chromatography-mass spectrometric analysis of the active principles from selected Chinese herbs and other medicinal plants. AMERICAN JOURNAL OF CHINESE MEDICINE, 2003, vol. 31, no. 6, p. 927-944. DOI
- Ojala, T., Vuorela, P., Kiviranta, J., Vuorela, H., Hiltunen, R. A bioassay using Artemia salina for detecting phototoxicity of plant coumarins . Planta medica, 1999, vol. 65, no. 8, p. 715-718. DOI
- Dhalwal, Kamlesh., Shinde, Vaibhav M., Mahadik, Kakasaheb R. Efficient and sensitive method for quantitative determination and validation of umbelliferone, carvone and myristicin in Anethum graveolens and Carum carvi seed . Chromatographia, 2008, vol. 67, no. 1-2, p. 163-167. DOI
- Abudayyak, Mahmoud., Ozdemir Nath, Ebru., Ozhan, Gul. Toxic potentials of ten herbs commonly used for aphrodisiac effect in Turkey. TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, vol. 45, no. 3, p. 496-506. DOI
- Dranik, L. I., Prokopenko, A. P. Coumarins and acids from Anethum graveolens fruit. Khimiya prirodnykh soedinenii, 1969, vol. 5, no. 5, p. 437.
- Amanpour, Asghar., Kelebek, Hasim., Selli, Serkan. Aroma constituents of shade-dried aerial parts of Iranian dill (Anethum graveolens L.) and savory (Satureja sahendica Bornm.) by solvent-assisted flavor evaporation technique . Journal of food measurement and characterization, 2017, vol. 11, no. 3, p. 1430-1439. DOI
- Malihezaman, Monsefi., Mojaba, Masoudi., Elham, Hosseini., Farnaz, Gramifar., Ramin, Miri. ANTI-FERTILITY EFFECTS OF DIFFERENT FRACTIONS OF ANETHUM GRAVEOLENS L. EXTRACTS ON FEMALE RATS . African journal of traditional complementary and alternative medicines, 2012, vol. 9, no. 3, p. 336-341. DOI
- Mahran, G.H., Kadry, H.A., Thabet, C.K., El-Olemy, M.M., Al-Azizi, M.M., Schiff, P.L., Wong, L.K., Liv, N. GC/MS analysis of volatile oil of fruits of anethum graveolens. Pharmaceutical biology, 1992, vol. 30, no. 2, p. 139-144. DOI
- Baslas, B. K., Baslas, R. K. Chemistry of the oil from the herb Anethum graveolens. Riechstoffe, aromen, koerperpflegemittel, 1972, vol. 22, no. 5), 155-, p. 158.
- Alam, P., Alqasoumi, S.I., Abdel-Kader, S.M.S., Abdel-Kader, M.S. Densitometric HPTLC methods for qualitative and quantitative analysis of carvone, dillapiole, methylparaben and propylparaben in dill, caraway seeds and pharmaceutical formulations utilizing normal and reversed-phase silica gel plates. Fabad journal of pharmaceutical sciences, 2013, vol. 38, no. 1, p. 33-48.
- Ortan, Alina., Popescu, Maria-Lidia., Gaita, Andreea-Liana., Dinu-Pirvu, Cristina., Campeanu, Gh. Contributions to the Pharmacognostical Study on Anethum graveolens, Dill (Apiaceae) . Romanian biotechnological letters, 2009, vol. 14, no. 2, p. 4342-4348.
Boundary
A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.
Continue
Europe PMC
Every record indexed for this species, resolvable and re-runnable.
All speciesSubstance index
Search and browse every species this world holds under source and hash.
Before anything elseSafety Centre
Interactions, contraindications and the escalation boundary this world does not cross.
In its own termsTraditions
How the living traditions approach preparation, use and context.